Xtant Medical Inc. (XTNT) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Xtant Medical Inc.

    AMEX: XTNT · Real-Time Price · USD
    0.63
    0.00 (0.43%)
    At close: Sep 25, 2025, 10:03 AM

    Xtant Medical Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 117.27M 91.3M 57.97M 55.26M
    Cost of Revenue
    		 49.05M 35.84M 25.83M 22.77M
    Gross Profit
    		 68.22M 55.47M 32.14M 32.49M
    Operating Income
    		 -12.07M -10.16M -6.75M -3.85M
    Interest Income
    		 n/a 149K 31K n/a
    Pretax Income
    		 -16.26M -1.04M -8.42M -4.85M
    Net Income
    		 -16.45M 660K -8.48M -4.85M
    Selling & General & Admin
    		 77.91M 64.29M 37.98M 35.47M
    Research & Development
    		 2.38M 1.34M 915K 870K
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 80.29M 65.63M 38.89M 36.34M
    Interest Expense
    		 4.16M 2.94M 1.69M 995K
    Selling & Marketing Expenses
    		 49.21M 38.44M 22.52M 21.02M
    Cost & Expenses
    		 129.34M 101.46M 64.72M 59.12M
    Income Tax Expense
    		 187K -1.7M 69K 995K
    Shares Outstanding (Basic)
    		 133.67M 119.09M 94.09M 85.46M
    Shares Outstanding (Diluted)
    		 133.67M 126.79M 94.09M 85.46M
    EPS (Basic)
    		 -0.12 0.01 -0.09 -0.06
    EPS (Diluted)
    		 -0.12 0.01 -0.09 -0.06
    EBITDA
    		 -7.88M 5.08M -5.43M -2.51M
    EBIT
    		 -12.1M 1.9M -6.72M -3.85M
    Depreciation & Amortization
    		 4.22M 3.17M 1.3M 1.34M

    Add to Watchlist